These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9462837)

  • 1. The carboxyl-terminal domain of insulin-like growth factor-I receptor interacts with the insulin receptor and activates its protein tyrosine kinase.
    Li S; Termini J; Hayward A; Siddle K; Zick Y; Koval A; LeRoith D; Fujita-Yamaguchi Y
    FEBS Lett; 1998 Jan; 421(1):45-9. PubMed ID: 9462837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of insulin and insulin-like growth factor I receptors investigated using chimeric mini-receptors. Role of C-terminal of receptor alpha subunit.
    Kristensen C; Wiberg FC; Andersen AS
    J Biol Chem; 1999 Dec; 274(52):37351-6. PubMed ID: 10601304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from an extracellular domain selectively inhibits receptor internalization: target sequences on insulin and insulin-like growth factor 1 receptors.
    Naranda T; Goldstein A; Olsson L
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11692-7. PubMed ID: 9326672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
    Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
    Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
    Dey BR; Furlanetto RW; Nissley P
    Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner.
    Craparo A; Freund R; Gustafson TA
    J Biol Chem; 1997 Apr; 272(17):11663-9. PubMed ID: 9111084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
    Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV
    Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system.
    Tartare-Deckert S; Murdaca J; Sawka-Verhelle D; Holt KH; Pessin JE; Van Obberghen E
    Endocrinology; 1996 Mar; 137(3):1019-24. PubMed ID: 8603569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function.
    Faria TN; Blakesley VA; Kato H; Stannard B; LeRoith D; Roberts CT
    J Biol Chem; 1994 May; 269(19):13922-8. PubMed ID: 8188672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor.
    Furlanetto RW; Dey BR; Lopaczynski W; Nissley SP
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):765-71. PubMed ID: 9581554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
    Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW
    Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two sequences flanking the major autophosphorylation site of the insulin receptor are essential for tyrosine kinase activation.
    Leconte I; Clauser E
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):465-72. PubMed ID: 7887900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of human p55 gamma, a regulatory subunit of phosphatidylinositol 3-kinase, by a yeast two-hybrid library screen with the insulin-like growth factor-I receptor.
    Dey BR; Furlanetto RW; Nissley SP
    Gene; 1998 Mar; 209(1-2):175-83. PubMed ID: 9524259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors.
    Maggi D; Cordera R
    Biochem Biophys Res Commun; 2001 Jan; 280(3):836-41. PubMed ID: 11162597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin receptor structure and its implications for the IGF-1 receptor.
    Lawrence MC; McKern NM; Ward CW
    Curr Opin Struct Biol; 2007 Dec; 17(6):699-705. PubMed ID: 17851071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase.
    Grønborg M; Wulff BS; Rasmussen JS; Kjeldsen T; Gammeltoft S
    J Biol Chem; 1993 Nov; 268(31):23435-40. PubMed ID: 7693688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation.
    O'Neill TJ; Zhu Y; Gustafson TA
    J Biol Chem; 1997 Apr; 272(15):10035-40. PubMed ID: 9092546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions.
    Liu D; Zong CS; Wang LH
    J Virol; 1993 Nov; 67(11):6835-40. PubMed ID: 7692086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.